Preferences and Decision Needs of Boston‐Area Travelers to Countries With Risk of Yellow Fever Virus Transmission: Implications for Health Care Providers
Author(s) -
Beth A. Lown,
Lin H. Chen,
Pauline Han,
Emily S. Jentes,
Mary Wilson,
Christine Benoit,
Karen A. Avery,
Winnie W. Ooi,
Davidson H. Hamer,
Elizabeth D. Barnett
Publication year - 2014
Publication title -
journal of travel medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.985
H-Index - 59
eISSN - 1708-8305
pISSN - 1195-1982
DOI - 10.1111/jtm.12119
Subject(s) - medicine , yellow fever vaccine , yellow fever , vaccination , travel medicine , family medicine , adverse effect , transmission (telecommunications) , environmental health , medical emergency , immunology , virus , psychiatry , electrical engineering , engineering
Yellow fever (YF), a potentially fatal mosquito-borne infection, is preventable with a live-attenuated vaccine, rarely associated with severe adverse events. We surveyed travelers to assess their reasons for pre-travel medical consultation, information they considered important regarding YF disease and vaccination, whether they recalled receiving this information, and whether they were involved in vaccine decision-making.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom